<DOC>
	<DOCNO>NCT00750087</DOCNO>
	<brief_summary>primary purpose study observe symptom control schizophrenia 6 month patient treat Seroquel XR . PLEASE NOTE : Seroquel SR Seroquel XR refer formulation . The SR designation change XR consultation FDA .</brief_summary>
	<brief_title>Non-interventional Study -Observe Treatment Efficacy Maintaining Symptoms Control Schizophrenia With Seroquel XR</brief_title>
	<detailed_description />
	<mesh_term>Schizophrenia</mesh_term>
	<mesh_term>Quetiapine Fumarate</mesh_term>
	<criteria>Patients diagnosis schizophrenia , define DSMIVTR symptom control Seroquel XR therapy start approximately 1 month All eligible patient include protocol provide receive detailed information advance sign consent grant access data collect programme . All patient know hypersensitivity Seroquel XR/quetiapine excipients include study . As per valid Romanian SmPC , concomitant medication , could result drug interaction could jeopardise patient safety carefully consider patient enrol .</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2010</verification_date>
	<keyword>Schizophrenia</keyword>
</DOC>